Nucleic Acid-Based Therapy Approaches for Huntington's Disease
Huntington's disease (HD) is caused by a dominant mutation that results in an unstable expansion of a CAG repeat in the huntingtin gene leading to a toxic gain of function in huntingtin protein which causes massive neurodegeneration mainly in the striatum and clinical symptoms associated with t...
Saved in:
Main Authors: | Tatyana Vagner, Deborah Young, Alexandre Mouravlev |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Neurology Research International |
Online Access: | http://dx.doi.org/10.1155/2012/358370 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Use of Nucleic Acid Analogs for the Study of Nucleic Acid Interactions
by: Shu-ichi Nakano, et al.
Published: (2011-01-01) -
Dioxaphosphorinane-Constrained Nucleic Acid Dinucleotides as Tools for Structural Tuning of Nucleic Acids
by: Dan-Andrei Catana, et al.
Published: (2012-01-01) -
Advances in nucleic acid-based cancer vaccines
by: Hung-Chun Liao, et al.
Published: (2025-01-01) -
The Role of the Immune System in Huntington’s Disease
by: Gisa Ellrichmann, et al.
Published: (2013-01-01) -
Cationic Cyclodextrin-Based Carriers for Drug and Nucleic Acid Delivery
by: Adila Nazli, et al.
Published: (2025-01-01)